Focused on cortisol, fueled by independence
Corcept Therapeutics (corcept.com) earns a Brand Analyzer score of 81 out of 100, placing it in the Strong Brand tier among Healthcare brands. Among 3446 Healthcare brands analyzed, Corcept Therapeutics ranks in the 83rd percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 73/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 90/100, AI Discoverability 85/100, Brand Authority 46/100.
Corcept Therapeutics is an American pharmaceutical company founded in 1998 and headquartered in Menlo Park, California. The company focuses on cortisol modulation science, developing therapies for serious diseases in which excess cortisol activity plays a critical role. Corcept positions itself as an independent, research-driven leader in this specialized therapeutic area, serving patients with cortisol-related disorders as well as the healthcare providers, researchers, and clinical investigators who treat and study these conditions.
| Brand Name | Corcept Therapeutics |
|---|---|
| Domain | corcept.com |
| Industry | Healthcare |
| Founded | 1998 |
| Headquarters | Menlo Park |
| Main Competitors | Novartis (73/100), Recordati (75/100), Xeris Biopharma (73/100), Crinetics Pharmaceuticals, Ionis Pharmaceuticals (79/100) |
Moz Domain Authority 43/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #565,102 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Corcept Therapeutics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Corcept advances cortisol modulation therapies to treat serious diseases. Learn more about our research, innovation, and commitment to better health." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: PHP, Apache, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Instagram; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Corcept Therapeutics scores 59/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Corcept Therapeutics has a limited AI-visibility profile at 59/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is trust (48/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #565,102 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Corcept Therapeutics's main competitors include Novartis (84/100), Recordati, Xeris Biopharma, Crinetics Pharmaceuticals, Ionis Pharmaceuticals (79/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Corcept Therapeutics and Novartis are competitors in Healthcare. Brand Analyzer scores Corcept Therapeutics at 81/100 and Novartis at 84/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Corcept Therapeutics include Novartis (84/100), Recordati, Xeris Biopharma, Crinetics Pharmaceuticals, Ionis Pharmaceuticals (79/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Corcept Therapeutics has moderate AI-search visibility, scoring 59/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 48, recommendation 57). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Corcept Therapeutics official site
Corcept Therapeutics was founded in 1998. Corcept Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Corcept Therapeutics is headquartered in Menlo Park. Corcept Therapeutics operates in the Healthcare category.
Sources: Wikidata
Corcept Therapeutics scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Corcept Therapeutics official site
Corcept Therapeutics is an American pharmaceutical company founded in 1998 and headquartered in Menlo Park, California. It specializes in cortisol modulation science, developing therapies aimed at treating serious diseases in which excess cortisol activity is a key factor.
Sources: Corcept Therapeutics official site
Corcept Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Corcept Therapeutics official site
Corcept Therapeutics researches and develops cortisol modulation therapies intended to treat serious diseases linked to excess cortisol activity. The company positions itself as an independent, science-driven organization focused on advancing this specialized field of medicine.
Sources: Corcept Therapeutics official site
Corcept Therapeutics' work is intended for patients suffering from serious diseases linked to cortisol dysregulation, as well as healthcare providers, researchers, and clinical investigators involved in treating and studying these conditions.
Sources: Corcept Therapeutics official site
Ranked closest to Corcept Therapeutics: Compliancy Group (81/100), CommonSpirit Health (81/100), CPR.io (81/100), Current Health (81/100).
A step up - brands to learn from: Oura (91/100), Olay (91/100).
Category leader: Elsevier (96/100).